US Broker Ratings

Neuronetics, Inc. (STIM) Stock Analysis: Unpacking the 53% Upside Potential

Neuronetics, Inc. (NASDAQ: STIM), a pioneering player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to treating neurohealth disorders. Headquartered in Malvern,..

DocuSign, Inc. (DOCU) Stock Analysis: Unpacking a Potential 18.82% Upside Amid Strong Analyst Ratings

For investors keen on the technology sector, DocuSign, Inc. (NASDAQ: DOCU) presents a compelling opportunity. Known for its electronic signature solutions and intelligent agreement management (IAM) platforms, DocuSign has carved..

aTyr Pharma, Inc. (ATYR) Stock Analysis: Exploring a 262% Potential Upside with Strong Buy Ratings

aTyr Pharma, Inc. (NASDAQ: ATYR) is a compelling player in the biotechnology sector, making waves with its innovative approach to treating fibrosis and inflammatory diseases. With a market capitalization of..

Immutep Limited (IMMP) Stock Analysis: A Biotech Gem with a 442% Upside Potential

Immutep Limited (NASDAQ: IMMP), an Australian biotechnology company, is making waves in the healthcare sector with its innovative LAG-3 related immunotherapies. With a market capitalization of $254.73 million, the company..

Quantum-Si Incorporated (QSI) Investor Outlook: Exploring a 94.65% Potential Upside

Quantum-Si Incorporated (NASDAQ: QSI), a promising player in the healthcare sector focusing on medical devices, has garnered attention due to its innovative contributions to Next Generation Protein Sequencing (NGPS). With..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: A Promising 168% Upside Awaits Investors

For investors seeking opportunities in the healthcare sector, particularly within the medical device industry, ClearPoint Neuro Inc. (NASDAQ: CLPT) presents a compelling case worth deeper consideration. Despite its relatively modest..

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Unveiling a 245% Potential Upside

Investors keeping an eye on the biotechnology sector should take a closer look at Heron Therapeutics, Inc. (NASDAQ: HRTX), a company that presents a compelling growth narrative. Operating within the..

Cidara Therapeutics (CDTX) Stock Analysis: Strong Buy Ratings Signal Promising Growth Potential

Cidara Therapeutics, Inc. (CDTX), a biotechnology company headquartered in San Diego, California, is garnering attention with a robust market cap of $1.37 billion. Specializing in developing targeted therapies for serious..

InterDigital, Inc. (IDCC) Stock Analysis: Exploring Growth Potential Amidst Strong Revenue Growth and Elevated Valuation

InterDigital, Inc. (NASDAQ: IDCC) stands as a formidable player in the technology sector, specializing in the development and licensing of wireless, visual, and artificial intelligence technologies. With a market capitalization..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: A Potential 222.95% Upside for Biotech Investors

Cartesian Therapeutics, Inc. (RNAC), a clinical-stage biotechnology firm, presents a compelling opportunity for investors seeking exposure to the innovative healthcare sector. Known for its pioneering work in mRNA cell therapies,..

Agora, Inc. (API) Stock Analysis: Unlocking a 62.63% Potential Upside in the Real-Time Engagement Sector

Agora, Inc. (NASDAQ: API) stands as a prominent player in the technology sector, particularly within the software application industry, with a unique focus on real-time engagement solutions. As the company..

Quhuo Limited (QH) Stock Analysis: Navigating Challenges with a 52-Week Low

Quhuo Limited (QH) is a name that might not yet be on every investor’s radar, but its unique position in the gig economy landscape of China offers intriguing prospects. Based..

Kaltura, Inc. (KLTR) Stock Analysis: Evaluating a Potential 75% Upside in the SaaS Sector

Kaltura, Inc. (KLTR) is making waves in the technology sector, particularly within the software-application industry, as it specializes in software-as-a-service (SaaS) and platform-as-a-service (PaaS) offerings. With its current market capitalization..

TotalEnergies SE (TTE) Investor Outlook: Solid Dividend Yield and 14.51% Potential Upside

TotalEnergies SE (TTE), a major player in the global energy sector, offers a compelling investment opportunity with its robust dividend yield and significant potential upside. With a market capitalization of..

CS Disco, Inc. (LAW) Stock Analysis: With a 47% Potential Upside, Is This Tech Stock a Buy?

CS Disco, Inc. (NYSE: LAW), a key player in the legal technology sector, is garnering increased attention from investors due to its innovative AI-powered legal solutions and a notable potential..

Sprout Social, Inc (SPT) Stock Analysis: Exploring a 66.56% Potential Upside in the Tech Sector

Sprout Social, Inc (NASDAQ: SPT), a prominent player in the technology sector, specializes in providing a comprehensive web-based social media management platform. This Chicago-based company has carved out a niche..

Sanara MedTech Inc. (SMTI) Stock Analysis: Unlocking a 99.59% Upside Potential

Sanara MedTech Inc. (NASDAQ: SMTI), a healthcare stalwart in the medical instruments & supplies industry, has been making waves with its innovative approach to wound care and surgical solutions. Based..

Olema Pharmaceuticals, Inc. (OLMA): A Biotech Stock with a Potential 396% Upside

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) has recently captured the attention of investors with its substantial potential upside and robust analyst ratings. This San Francisco-based clinical-stage biopharmaceutical company is dedicated to..

Yalla Group Limited (YALA) Stock Analysis: Navigating a Promising Path in the MENA Tech Space

Yalla Group Limited (NYSE: YALA), a prominent social networking and gaming platform in the Middle East and North Africa (MENA) region, has been capturing investor attention amidst its impressive stock..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: Unpacking a Potential 37% Upside in the Biotech Sector

In the ever-evolving landscape of biotechnology, Palvella Therapeutics, Inc. (NASDAQ: PVLA) is making waves with its innovative approach to rare genetic skin diseases. With a market cap of $431.95 million,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds